Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
lululemon athletica (LULU) CEO Depature Unlikely to Impact Business - Canaccord
-
Broadcom (BRCM): Qualcomm Accretive To $100 - Canaccord
-
TransDigm Group (TDG): Short Cycle Defense Should Drive Upside, PT To $315 - Canaccord
-
Roper Industries (ROP) PT Raised to $310 at Canaccord Genuity Following 4Q Report
-
Michael Kors (KORS) PT Raised to $81 at Canaccord Genuity
-
Edwards Lifesciences (EW) PT Raised to $174 at Canaccord Genuity
-
Deckers Outdoor (DECK) PT Raised to $110 at Canaccord Genuity Following 3Q
-
Alphabet (GOOGL): More Growth But With Gross Margin Pressure - Canaccord
-
Apple (AAPL) PT Maintained at $200 at Canaccord Genuity on 1Q18 Beat; 'Lowering iPhone Estimates, but Strong EPS Trends Should Continue'
-
Amazon.com (AMZN) PT Raised to $1,650 at Canaccord Genuity, 'Q4 shows Alexa has not lost her voice'
-
Canaccord Genuity Downgrades Impinj Inc (PI) to Hold
-
MiX Telematics (MIXT) PT Raised to $20 at Canaccord Genuity
-
IMAX Corporation (IMAX) PT Lowered to $26 at Canaccord Genuity Amid Weak Boxoffice
-
Tetra Tech (TTEK) PT Raised to $60 at Canaccord Genuity; Positive Drivers Intact
-
Microsoft (MSFT) PT Raised to $105 at Canaccord Genuity on 2Q Beat; 'Upside Across the Board... Azure Continued Impressive Growth'
-
Facebook soothes market nerves with user experience promise
-
Ericsson (ERIC) PT Lowered to $6 at Canaccord Genuity
-
Boeing (BA) PT Raised to $345 at Canaccord Genuity
-
Broadcom Limited (AVGO) PT Raised to $325 at Canaccord Genuity
-
Qorvo Inc (QRVO) PT Raised to $89 at Canaccord Genuity on 3Q Beat; 'Gross Margins Remain Steady with Strong Execution'
-
ServiceNow (NOW): More Good News To Come - Canaccord
-
bluebird bio (BLUE): ASCO Likely A Positive Catalyst, PT to $250 - Canaccord
-
Facebook (FB) PT Raised to $240 at Canaccord Genuity, Pleased With Co Focus On High-Quality Engagement Over Time-Spent
-
Stryker (SYK) PT Raised to $176 at Canaccord Genuity on 4Q; 'Abundant New Product Cycles to Support Execution'
-
Crane (CR) PT Raised to $110 at Canaccord Genuity
-
U.S. stock pullback stokes fears of more volatility
-
Canaccord Genuity Retierates Hold Rating & $1100 PT on Alphabet (GOOGL) Ahead of 4Q Earnings Announcement on 2/1; 'Core Revenue Growth Should Stay Above 20% This Year'
-
Amazon.com (AMZN) PT Maintained at $1,500 at Canaccord Genuity on 4Q Preview; 'Most Robust L-T Growth Opportunity in Internet Group'
-
Facebook (FB) PT Maintained at $230 at Canaccord Genuity on 4Q Preview; 'Multi-Faceted Growth Story is Still Intact'
-
Canaccord Genuity Remains Bullish on ATARA Biotherapeutics (ATRA)
-
Deckers Outdoor (DECK) PT Raised to $100 at Canaccord Genuity; Reiterates Buy
-
VF Corp. (VFC) PT Raised to $90 at Canaccord Genuity
-
Abaxis Inc. (ABAX) PT Raised to $65 at Canaccord Genuity
-
IDEXX Laboratories (IDXX) PT Raised to $210 at Canaccord Genuity, Street High
-
Intuitive Surgical (ISRG): Strong Fundamentals Priced In - Canaccord
-
LSI Industries (LYTS) PT Raised to $10 at Canaccord Genuity Following Q2 Earnings Report
-
Histogenics Corporation Announces Closing of Underwritten Registered Direct Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
-
Canaccord Genuity's US Research team cites RYU Apparel positioned within "Retail's Next Growth Areas."
-
ConforMIS Inc (CFMS) Prices 13.33M Shares Common Offering at $1.50/Sh
-
ConforMIS Announces Pricing of Public Offering of Common Stock
-
Aspen Technology (AZPN) PT Raised to $73 at Canaccord Genuity, Says Equity is Too Expensive for a Buy Rating
-
Aerie Pharma (AERI): Few Hurdles Ahead Of Rhopressa Launch - Canaccord
-
Canaccord Genuity Adds Dedicated Cannabis Investment Banking and Advisory Expertise in the U.S.
-
ConforMIS Inc (CFMS) Announces Proposed Common Share Offering
-
ConforMIS Announces Proposed Public Offering of Common Stock
-
Biogen (BIIB) PT Raised to $350 at Canaccord Genuity Ahead of 4Q17 Earnings Announcement on 1/25 BMO; 'Lower Tax Rate in 2018+ Main Driver'
-
Record Attendance at Canaccord Genuity Blockchain Conference
-
Aurora Cannabis and CanniMed Therapeutics Agree to Terms on Friendly Transaction
-
Skyworks Solutions (SWKS) PT Lowered to $115 at Canaccord Genuity on 'Softer 1H/C2018 iPhone Estimates'
-
UPDATE: Apple (AAPL) PT Raised to $200 at Canaccord Genuity on U.S. Smartphone Survey Data; 'Strong iPhone Sales During December Quarter'

